Wells Pharma of Houston LLC recalls fentaNYL Citrate Injectable Solution in 0.9% Sodium Chloride, 50 mcg/5mL)(10 mcg per mL), wells pharma, NDC 73702-202-15
Recalled May 6, 2026 · FDA recall D-0508-2026 · Wells Pharma of Houston
Hazard
cGMP deviations. · FDA Class II
Units
50 syringes
Sold at
U.S. Nationwide.
Description
cGMP deviations.
Product
fentaNYL Citrate Injectable Solution in 0.9% Sodium Chloride, 50 mcg/5mL)(10 mcg per mL), wells pharma, NDC 73702-202-15.
Manufacturer(s)
Wells Pharma of Houston LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →